- Tytuł:
- Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
- Autorzy:
- Źródło:
- In Lancet Oncology 2011 12(3):236-244
Czasopismo naukowe